UK markets closed

Biogen Inc. (IDP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
206.400.00 (0.00%)
As of 04:16PM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 29.92B
Enterprise value 35.36B
Trailing P/E 27.81
Forward P/E 14.33
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.36
Price/book (mrq)2.13
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.01
52-week change 3-27.27%
S&P500 52-week change 326.27%
52-week high 3307.40
52-week low 3178.30
50-day moving average 3196.55
200-day moving average 3221.60

Share statistics

Avg vol (3-month) 333
Avg vol (10-day) 399
Shares outstanding 5145.6M
Implied shares outstanding 6147.01M
Float 8145.05M
% held by insiders 10.16%
% held by institutions 194.37%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.07%
Operating margin (ttm)27.28%

Management effectiveness

Return on assets (ttm)4.86%
Return on equity (ttm)8.05%

Income statement

Revenue (ttm)9.66B
Revenue per share (ttm)66.69
Quarterly revenue growth (yoy)-7.00%
Gross profit (ttm)N/A
EBITDA 2.52B
Net income avi to common (ttm)1.17B
Diluted EPS (ttm)7.43
Quarterly earnings growth (yoy)1.40%

Balance sheet

Total cash (mrq)1.07B
Total cash per share (mrq)7.38
Total debt (mrq)6.95B
Total debt/equity (mrq)45.66%
Current ratio (mrq)2.10
Book value per share (mrq)104.49

Cash flow statement

Operating cash flow (ttm)1.65B
Levered free cash flow (ttm)899.92M